Kaitlin has been with Oximio BARL Canada for more than 10 years. As Managing Director, she oversees the planning, direction, and management of operations, while also guiding the organization’s strategic vision and future growth.
She holds a Bachelor of Arts from Brock University, a Pharmacy Technician Diploma from Niagara College, and an MBA from Athabasca University. With this diverse academic background, Kaitlin ensures that operations run compliantly, efficiently, and with customer care at the forefront.
Erin Gunduz is a senior Quality and Regulatory Affairs leader in the in vitro diagnostics and medical device space, with deep experience across IVDR, MDR and FDA regulatory frameworks. She focuses on building modular, pragmatic, and risk-based strategies to enable successful product development and lifecycle maintenance, while advocating the role of compliance as the foundation for confident and evidence-driven decision-making.
Dynamic and experienced leader with a proven track record of guiding teams and managing complex projects to achieve strategic objectives in both local and global settings. Excels at identifying and resolving challenges, designing sustainable solutions, and maintaining high standards while ensuring alignment with organizational goals. Demonstrated expertise in strategic planning, project and change management, and problem-solving, with a strong focus on driving continuous improvement and delivering impactful results.
Leslie Pibouleau works as a policy officer in the European Commission in the Unit of the Directorate General for Health and Food Safety (DG SANTE) in charge of the State of Health, the European Semester, and Health Technology Assessment. Leslie is a biomedical engineer by background with a PhD in public health on statistical methods for medical devices. She has been working on medical devices and their clinical evaluation in many different capacities since 2000, both in the private and the public sector: Medtech companies, Contract Research Organisations, the French HTA body (Haute Autorité de Santé), the European Medicines Agency where she kickstarted the work of the expert panels secretariat as well as the European Commission where she currently works on the implementation of the HTA Regulation.
Sophie graduated from the University of Liverpool with a BSc in Biological Sciences in 2022. She has since completed a master’s in Clinical Drug Development at University College London, where she undertook a dissertation looking at the differences in the clinical presentation between adults and pediatrics with systemic lupus erythematosus. Following on from this, Sophie has a strong interest in the medical sectors.
Ben Franks FRSA is a former wine journalist turned entrepreneur, best known for founding the award-winning wine merchant Novel Wines and co-founding Canned Wine Group, where today he is CCO and wine buyer. Ben was named ‘Leadership Champion’ and listed in Harper’s 30 Under 30 in 2024 and has been described as ‘a shining example of the entrepreneurial spirit’ by The Buyer and a ‘visionary entrepreneur’ by the IEWA. Alongside his own businesses, Ben is an investor and advisor to other wine and spirits brands, particularly those looking to launch in the UK market. Since 2020 he has been a Fellow of the Royal Society of Arts, recognising his work in start-ups and entrepreneurship.
Martin Jarvis is a buying manager passionate about driving sustainable innovation in the food industry. With a strong focus on ethical sourcing, Martin combines strategic thinking with creative problem-solving to deliver solutions that reduce environmental impact while enhancing product quality and brand value. He champions collaboration with suppliers to foster transparency, resilience, and long-term sustainability, ensuring that innovation aligns with both consumer expectations and global responsibility.
